Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Aditya Belamkar, Alon Harris, Ryan Zukerman, Brent Siesky, Francesco Oddone, Alice Verticchio Vercellin & Thomas A. Ciulla. (2022) Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications. Annals of Medicine 54:1, pages 343-358.
Read now
Read now
Mohammad Pakravan, Afsaneh Naderi Beni, Shahin Yazdani, Hamed Esfandiari & Shahram Mirshojaee. (2021) Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma. Journal of Drug Assessment 10:1, pages 91-96.
Read now
Read now
Arun Joseph & Louis R. Pasquale. (2017) Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence. Seminars in Ophthalmology 32:1, pages 86-90.
Read now
Read now
Elad Moisseiev, Shimon Kurtz, Moshe Lazar & Gabi Shemesh. (2013) Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily. Clinical Ophthalmology 7, pages 1269-1273.
Read now
Read now
Gabi Shemesh, Elad Moisseiev, Moshe Lazar & Shimon Kurtz. (2012) Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day. Clinical Ophthalmology 6, pages 283-287.
Read now
Read now
M Reza Razeghinejad, Andrea K Sawchyn & L Jay Katz. (2010) Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma. Expert Opinion on Pharmacotherapy 11:6, pages 959-968.
Read now
Read now
Gábor Holló, Banu Bozkurt & Murat Irkec. (2009) Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension. Expert Opinion on Pharmacotherapy 10:12, pages 2015-2024.
Read now
Read now
Jason Yeh, Daniel Kravitz & Brian Francis. (2008) Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma. Clinical Ophthalmology 2:2, pages 389-399.
Read now
Read now
Articles from other publishers (12)
Justin Gatwood, Callee Brooks, Ryan Meacham, Joseph Abou-Rahma, Alina Cernasev, Eric Brown & Rachel W. Kuchtey. (2022) Facilitators and Barriers to Glaucoma Medication Adherence. Journal of Glaucoma 31:1, pages 31-36.
Crossref
Crossref
Josef Flammer & Katarzyna Konieczka. (2017) The discovery of the Flammer syndrome: a historical and personal perspective. EPMA Journal 8:2, pages 75-97.
Crossref
Crossref
Shigeki Kobayashi. (2013) Intraocular Pressure-Reducing Effects After Treatment is Changed to Cosopt<sup>®</sup> Monotherapy in Broadly Defined Primary Open-Angle Glaucoma or Ocular Hypertension広義の原発性開放隅角緑内障もしくは高眼圧症に対するコソプト<sup>®</sup>点眼液に変更後の眼圧下降効果. Nihon Ika Daigaku Igakkai Zasshi 9:3, pages 152-155.
Crossref
Crossref
Albert S Khouri, Tony Realini & Robert D Fechtner. (2007) Use of Fixed-Dose Combination Drugs for the Treatment of Glaucoma. Drugs & Aging 24:12, pages 1007-1016.
Crossref
Crossref
T. S. Dietlein. (2006) Glaukom im Alter – Barrieren für Aufklärung und ComplianceGlaucoma in the aged – barriers to understanding and compliance. Der Ophthalmologe 103:9, pages 755-758.
Crossref
Crossref
Trish A Gray, Lois C Orton, David Henson, Robert Harper & Heather Waterman. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Caryn E. Plummer, Edward O. MacKay & Kirk N. Gelatt. (2006) Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs. Veterinary Ophthalmology 9:4, pages 245-249.
Crossref
Crossref
James E Frampton & Caroline M Perry. (2006) Topical Dorzolamide 2%/Timolol 0.5% Ophthalmic Solution. Drugs & Aging 23:12, pages 977-995.
Crossref
Crossref
Gail F. Schwartz. 2006. Glaucoma. Glaucoma
91
105
.
Bret A Hughes, Jason Bacharach, E Randy Craven, Martin B Kaback, Sushanta Mallick, Theresa A Landry & Michael V W Bergamini. (2005) A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5% Dosed Concomitantly in Subjects With Open Angle Glaucoma or Ocular Hypertension. Journal of Glaucoma 14:5, pages 392-399.
Crossref
Crossref
Joel S. Schuman, Gregory J. Katz, Richard A. Lewis, J. Charles Henry, Sushanta Mallick, David T. Wells, E. Kenneth Sullivan, Theresa A. Landry, Michael V.W. Bergamini & Stella M. Robertson. (2005) Efficacy and Safety of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Once Daily for Open-Angle Glaucoma or Ocular Hypertension. American Journal of Ophthalmology 140:2, pages 242.e1-242.e11.
Crossref
Crossref
Robert D. Fechtner & Tony Realini. (2004) Fixed combinations of topical glaucoma medications. Current Opinion in Ophthalmology 15:2, pages 132-135.
Crossref
Crossref